The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult). These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes. An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease. According to our (Global Info Research) latest study, the global Human Microbiome market size was valued at USD 396 million in 2022 and is forecast to a readjusted size of USD 1483.8 million by 2029 with a CAGR of 20.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share. This report is a detailed and comprehensive analysis for global Human Microbiome market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Human Microbiome market size and forecasts, in consumption value ($ Million), 2018-2029 Global Human Microbiome market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Human Microbiome market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Human Microbiome market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Human Microbiome To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Human Microbiome market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vedanta, Seres Therapeutics, Second Genome, Rebiotix and ActoGeniX, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Human Microbiome market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Gastrointestinal Tract Human Micobiome Urogenital Tract Human Micobiome Others Market segment by Application Treatment Diagnosis Market segment by players, this report covers Vedanta Seres Therapeutics Second Genome Rebiotix ActoGeniX Enterome BioScience AvidBiotics 4D Pharma Research Ltd Enterologics Metabogen Metabiomics Ritter Pharmaceuticals Osel Symberix Miomics Symbiotix Biotherapies MicroBiome Therapeutics LLC Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Human Microbiome product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Human Microbiome, with revenue, gross margin and global market share of Human Microbiome from 2018 to 2023. Chapter 3, the Human Microbiome competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Human Microbiome market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Human Microbiome. Chapter 13, to describe Human Microbiome research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Human Microbiome 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Human Microbiome by Type 1.3.1 Overview: Global Human Microbiome Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Human Microbiome Consumption Value Market Share by Type in 2022 1.3.3 Gastrointestinal Tract Human Mi
